Heather Preston, Director at Fusion Pharmaceuticals Inc. (FUSN), bought 8,823 shares at $17.00 ($150K) on 2020-06-30, disclosed to the SEC on 2020-07-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KRTX | BUY | 2020-03-12 | $227K | — | Filing → |
| KRTX | BUY | 2020-01-10 | $56K | — | Filing → |
| KRTX | BUY | 2020-01-07 | $100K | — | Filing → |